Roquefort Therapeutics Statistics

Total Valuation

LON:ROQ has a market cap or net worth of GBP 2.32 million. The enterprise value is 2.39 million.

Market Cap	2.32M
Enterprise Value	2.39M

Important Dates

The last earnings date was Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	n/a

Share Statistics

LON:ROQ has 154.98 million shares outstanding.

Current Share Class	154.98M
Shares Outstanding	154.98M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+1.37%
Owned by Insiders (%)	29.10%
Owned by Institutions (%)	35.41%
Float	99.54M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	0.48
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.46
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.63, with a Debt / Equity ratio of 0.08.

Current Ratio	0.63
Quick Ratio	0.61
Debt / Equity	0.08
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-24.90

Financial Efficiency

Return on equity (ROE) is -18.71% and return on invested capital (ROIC) is -12.94%.

Return on Equity (ROE)	-18.71%
Return on Assets (ROA)	-11.79%
Return on Invested Capital (ROIC)	-12.94%
Return on Capital Employed (ROCE)	-21.60%
Revenue Per Employee	n/a
Profits Per Employee	-138,829
Employee Count	5
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -64.71% in the last 52 weeks. The beta is -0.35, so LON:ROQ's price volatility has been lower than the market average.

Beta (5Y)	-0.35
52-Week Price Change	-64.71%
50-Day Moving Average	1.77
200-Day Moving Average	3.25
Relative Strength Index (RSI)	32.42
Average Volume (20 Days)	751,582

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	-16,000
Operating Income	-1.12M
Pretax Income	-1.21M
Net Income	-971,803
EBITDA	-1.11M
EBIT	-1.12M
Earnings Per Share (EPS)	-0.01

Full Income Statement

Balance Sheet

The company has 337,112 in cash and 400,092 in debt, giving a net cash position of -62,980 or -0.00 per share.

Cash & Cash Equivalents	337,112
Total Debt	400,092
Net Cash	-62,980
Net Cash Per Share	-0.00
Equity (Book Value)	4.89M
Book Value Per Share	0.04
Working Capital	-217,323

Full Balance Sheet

Cash Flow

Operating Cash Flow	-783,731
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LON:ROQ does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-41.80%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a